-
Article
Biosynthesis of 2-aminooctanoic acid and its use to terminally modify a lactoferricin B peptide derivative for improved antimicrobial activity
Terminal modification of peptides is frequently used to improve their hydrophobicity. While N-terminal modification with fatty acids (lipidation) has been reported previously, C-terminal lipidation is limited ...
-
Article
Stabilization of Angiotensin-(1–7) by key substitution with a cyclic non-natural amino acid
Angiotensin-(1–7) [Ang-(1–7)], a heptapeptide hormone of the renin–angiotensin–aldosterone system, is a promising candidate as a treatment for cancer that reflects its anti-proliferative and anti-angiogenic pr...
-
Protocol
Using Disease-Associated Enzymes to Activate Antimicrobial Peptide Prodrugs
Prodrugs of antimicrobial peptides can be generated by modifying their sequences at their N-termini with a linker and a negatively charged promoiety. These modifications can be selectively reversed by a diseas...
-
Article
Open AccessIn vitro evaluation of a prodrug approach for Gly-D-P18, a host defence peptide and novel anticancer agent
-
Protocol
Computational Approaches to Develo** Short Cyclic Peptide Modulators of Protein–Protein Interactions
Cyclic peptides are a promising class of bioactive molecules potentially capable of modulating “difficult” targets, such as protein–protein interactions. Cyclic peptides have long been used as therapeutics der...
-
Article
Open AccessComputational survey of peptides derived from disulphide-bonded protein loops that may serve as mediators of protein-protein interactions
Bioactive cyclic peptides derived from natural sources are well studied, particularly those derived from non-ribosomal synthetases in fungi or bacteria. Ribosomally synthesised bioactive disulphide-bonded loop...
-
Article
In Vitro Investigations of the Efficacy of Cyclodextrin-siRNA Complexes Modified with Lipid-PEG-Octaarginine: Towards a Formulation Strategy for Non-viral Neuronal siRNA Delivery
Development of RNA interference based therapeutics for neurological and neurodegenerative diseases is hindered by a lack of non-viral vectors with suitable properties for systemic administration. Amphiphilic a...
-
Article
Bioinformatic discovery of novel bioactive peptides
-
Chapter and Conference Paper
Peptidomimetic Inhibitors of Platelet Adhesion as Potential Novel Antiplatelet Agents